Stevanato Group S.p.A. Ordinary Shares (STVN)
19.06
-0.26 (-1.35%)
Stevanato Group S.P.A. is a global leader in the design and manufacturing of drug containment and delivery solutions for the pharmaceutical and biotechnology industries
The company specializes in producing high-quality glass vials, syringes, and other packaging solutions that ensure the safe and effective delivery of medicines. Additionally, Stevanato Group offers integrated technologies and services, focusing on enhancing the performance of its products through innovative packaging systems and automation processes. The company’s commitment to quality, safety, and sustainability makes it a trusted partner for healthcare organizations seeking reliable and efficient solutions for their drug delivery needs.

Via Benzinga · February 14, 2025

Via Benzinga · February 14, 2025

Via Benzinga · December 31, 2024

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, STVN.
Via Benzinga · December 15, 2024

Via Benzinga · December 5, 2024

Top performing mid-cap stocks in the last week, including Semtech, Stevanato, Ambarella, Ardent Health, BILL, Box, and Grupo Financiero Galicia.
Via Benzinga · September 2, 2024

Via Benzinga · August 29, 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024

Via Benzinga · May 9, 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

Stevanato Group reports Q1 earnings of 236.0 million euros, down 1% Y/Y. Sales declined due to vial destocking amid pandemic effects. High-value solutions revenue up to 37% driven by syringe demand. Updated FY24 guidance reflects cautious outlook.
Via Benzinga · May 9, 2024

Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

Companies Reporting Before The Bell • CI&T (NYSECINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024

Via Benzinga · November 1, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · September 27, 2023

Stephens analyst Jacob Johnson initiated coverage on Stevanato Group SPA (NYSESTVN) at an Overweight rating
Via Benzinga · September 26, 2023

Companies Reporting Before The Bell • BBVA (NYSEBBVA) is likely to report earnings for its third quarter. • BP NYSE:BPNYSEBP)
Via Benzinga · October 31, 2023

Via Benzinga · September 26, 2023

Via Benzinga · September 19, 2023